IM Cannabis Statistics
Total Valuation
IM Cannabis has a market cap or net worth of $10.34 million. The enterprise value is $21.49 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IM Cannabis has 5.25 million shares outstanding. The number of shares has increased by 26.26% in one year.
| Current Share Class | 5.25M |
| Shares Outstanding | 5.25M |
| Shares Change (YoY) | +26.26% |
| Shares Change (QoQ) | +5.71% |
| Owned by Insiders (%) | 41.16% |
| Owned by Institutions (%) | 4.31% |
| Float | 2.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | 0.24 |
| PB Ratio | 3.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.07 |
| P/OCF Ratio | 5.68 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 12.31 |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of 3.85.
| Current Ratio | 0.72 |
| Quick Ratio | 0.38 |
| Debt / Equity | 3.85 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.57 |
| Interest Coverage | -1.04 |
Financial Efficiency
Return on equity (ROE) is -48.50% and return on invested capital (ROIC) is -14.23%.
| Return on Equity (ROE) | -48.50% |
| Return on Assets (ROA) | -7.17% |
| Return on Invested Capital (ROIC) | -14.23% |
| Return on Capital Employed (ROCE) | -78.71% |
| Revenue Per Employee | $404,533 |
| Profits Per Employee | -$15,181 |
| Employee Count | 95 |
| Asset Turnover | 1.29 |
| Inventory Turnover | 8.47 |
Taxes
| Income Tax | -93,851 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.82% in the last 52 weeks. The beta is 2.12, so IM Cannabis's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -9.82% |
| 50-Day Moving Average | 2.20 |
| 200-Day Moving Average | 2.23 |
| Relative Strength Index (RSI) | 49.69 |
| Average Volume (20 Days) | 73,935 |
Short Selling Information
The latest short interest is 6,526, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 6,526 |
| Short Previous Month | 7,641 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, IM Cannabis had revenue of $38.43 million and -$1.44 million in losses. Loss per share was -$0.54.
| Revenue | 38.43M |
| Gross Profit | 9.31M |
| Operating Income | -3.42M |
| Pretax Income | -1.79M |
| Net Income | -1.44M |
| EBITDA | -2.23M |
| EBIT | -3.42M |
| Loss Per Share | -$0.54 |
Full Income StatementBalance Sheet
The company has $582,171 in cash and $11.47 million in debt, giving a net cash position of -$10.89 million or -$2.08 per share.
| Cash & Cash Equivalents | 582,171 |
| Total Debt | 11.47M |
| Net Cash | -10.89M |
| Net Cash Per Share | -$2.08 |
| Equity (Book Value) | 2.98M |
| Book Value Per Share | 0.64 |
| Working Capital | -7.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.87 million and capital expenditures -$79,187, giving a free cash flow of $1.75 million.
| Operating Cash Flow | 1.87M |
| Capital Expenditures | -79,187 |
| Free Cash Flow | 1.75M |
| FCF Per Share | $0.33 |
Full Cash Flow StatementMargins
Gross margin is 24.23%, with operating and profit margins of -8.89% and -3.75%.
| Gross Margin | 24.23% |
| Operating Margin | -8.89% |
| Pretax Margin | -4.66% |
| Profit Margin | -3.75% |
| EBITDA Margin | -5.80% |
| EBIT Margin | -8.89% |
| FCF Margin | 4.54% |
Dividends & Yields
IM Cannabis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.26% |
| Shareholder Yield | -26.26% |
| Earnings Yield | -13.61% |
| FCF Yield | 16.47% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2024. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
IM Cannabis has an Altman Z-Score of -8.07 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.07 |
| Piotroski F-Score | 5 |
